Cargando…
Lactulose: A treatment for hyperammonemia in a lysinuric protein–intolerant patient with dynamic blood amino acid concentrations
Autores principales: | Kakisaka, Keisuke, Sato, Takuro, Wada, Yasunori, Ito, Ai, Eto, Hisashi, Abe, Hiroaki, Kanazawa, Jo, Yusa, Kenji, Kooka, Yohei, Endo, Kei, Yoshida, Yuichi, Oikawa, Takayoshi, Kuroda, Hidekatsu, Miyasaka, Akio, Akasaka, Manami, Matsumoto, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294522/ https://www.ncbi.nlm.nih.gov/pubmed/35865266 http://dx.doi.org/10.1016/j.ymgmr.2022.100898 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab
por: Endo, Kei, et al.
Publicado: (2022) -
Fanconi syndrome with lysinuric protein intolerance
por: Riccio, Eleonora, et al.
Publicado: (2014) -
Lysinuric protein intolerance presenting with multiple fractures
por: Posey, Jennifer E., et al.
Publicado: (2014) -
Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
por: Endo, Kei, et al.
Publicado: (2020) -
Plasma calprotectin is extremely high in patients with lysinuric protein intolerance
por: Kärki, Mari, et al.
Publicado: (2023)